Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial

Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:21:19.000Z thumbnail image
  3. Check
    27 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:42:43.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T06:24:59.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T21:37:32.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    0.2%
    Check dated 2025-01-12T17:17:32.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:36:38.000Z thumbnail image

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.